1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Targeting TUBG1 in RB1-negative tumors
2025) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39(5).(
- Contribution to journal › Article
- 2015
-
Mark
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
(
- Contribution to journal › Article